As of 2025-09-18, the Relative Valuation of Biosynex SA (ALBIO.PA) is (37.10) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 1.20 EUR, the upside of Biosynex SA based on Relative Valuation is -3191.7%.
The range of the Relative Valuation is (32.97) - (39.59) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 21.4x | 17.8x |
| Forward P/E multiples | 11.4x - 17.1x | 14.2x |
| Fair Price | (32.97) - (39.59) | (37.10) |
| Upside | -2847.3% - -3399.1% | -3191.7% |
| Date | P/E |
| 2025-09-15 | -0.53 |
| 2025-09-12 | -0.52 |
| 2025-09-11 | -0.53 |
| 2025-09-10 | -0.51 |
| 2025-09-09 | -0.51 |
| 2025-09-08 | -0.51 |
| 2025-09-05 | -0.51 |
| 2025-09-04 | -0.51 |
| 2025-09-03 | -0.51 |
| 2025-09-02 | -0.51 |
| 2025-09-01 | -0.51 |
| 2025-08-29 | -0.51 |
| 2025-08-28 | -0.51 |
| 2025-08-27 | -0.51 |
| 2025-08-26 | -0.51 |
| 2025-08-25 | -0.51 |
| 2025-08-22 | -0.52 |
| 2025-08-21 | -0.51 |
| 2025-08-20 | -0.51 |
| 2025-08-19 | -0.51 |
| 2025-08-18 | -0.51 |
| 2025-08-15 | -0.52 |
| 2025-08-14 | -0.51 |
| 2025-08-13 | -0.51 |
| 2025-08-12 | -0.51 |
| 2025-08-11 | -0.52 |
| 2025-08-08 | -0.53 |
| 2025-08-07 | -0.53 |
| 2025-08-06 | -0.53 |
| 2025-08-05 | -0.53 |
| 2025-08-04 | -0.52 |
| 2025-08-01 | -0.53 |
| 2025-07-31 | -0.56 |
| 2025-07-30 | -0.57 |
| 2025-07-29 | -0.52 |
| 2025-07-28 | -0.53 |
| 2025-07-25 | -0.53 |
| 2025-07-24 | -0.54 |
| 2025-07-23 | -0.53 |
| 2025-07-22 | -0.53 |
| 2025-07-21 | -0.54 |
| 2025-07-18 | -0.55 |
| 2025-07-17 | -0.55 |
| 2025-07-16 | -0.56 |
| 2025-07-15 | -0.55 |
| 2025-07-14 | -0.56 |
| 2025-07-11 | -0.55 |
| 2025-07-10 | -0.55 |
| 2025-07-09 | -0.55 |
| 2025-07-08 | -0.53 |